After Cantor Fitzgerald and Oppenheimer gave The Ensign Group (NASDAQ: ENSG) a Buy rating last month, the company received another Buy, this time from RBC Capital. Analyst Frank Morgan reiterated a Buy rating on The Ensign Group yesterday and set a price target of $38. The company’s shares closed on Friday at $35.05.
According to TipRanks.com, Morgan is a 5-star analyst with an average return of 16.2% and a 67.6% success rate. Morgan covers the Services sector, focusing on stocks such as Encompass Health Corporation, Fresenius Medical Care Corp, and Envision Healthcare.
Currently, the analyst consensus on The Ensign Group is a Strong Buy with an average price target of $40.80, representing a 16.4% upside. In a report issued on July 30, Cantor Fitzgerald also maintained a Buy rating on the stock with a $42 price target.
.
See today’s analyst top recommended stocks >>
Based on The Ensign Group’s latest earnings release for the quarter ending June 30, the company reported a quarterly net profit of $22.01 million. In comparison, last year the company had a net profit of $12.22 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
The Ensign Group, Inc. engages in the provision of healthcare services, as well as urgent care centers and mobile ancillary businesses. It operates through the following segments: Transitional and Skilled Services, Assisted and Independent Living Services, and Home Health and Hospice Services.
